Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

RPRX holding history

Royalty Pharma plc in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings

Shares (Q2 2026)
11,641
Value
$652.7K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of RPRX by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202611,641$652.7K<0.1%+777+7.2%AddedHolders
Q1 202610,864$521.1K<0.1%−2,690−19.8%ReducedHolders
Q4 202513,554$523.7K<0.1%−868−6.0%ReducedHolders
Q3 202514,422$508.8K<0.1%+40.0%AddedHolders
Q2 202514,418$519.5K<0.1%+935+6.9%AddedHolders
Q1 202513,483$419.7K<0.1%+3,918+41.0%AddedHolders
Q4 20249,565$244.0K<0.1%+5,759+151.3%AddedHolders
Q3 20243,806$107.7K<0.1%−2,050−35.0%ReducedHolders
Q2 20245,856$154.4K<0.1%−3,527−37.6%ReducedHolders
Q1 20249,383$285.0K<0.1%+864+10.1%AddedHolders
Q4 20238,519$239.3K<0.1%+4,759+126.6%AddedHolders
Q3 20233,760$102.1K<0.1%+1,469+64.1%AddedHolders
Q2 20232,291$70.4K<0.1%−3,248−58.6%ReducedHolders
Q1 20235,539$199.6K<0.1%+1,184+27.2%AddedHolders
Q4 20224,355$172.1K<0.1%−626−12.6%ReducedHolders
Q3 20224,981$201.0K<0.1%−6,889−58.0%ReducedHolders
Q2 202211,870$499.0K<0.1%+765+6.9%AddedHolders
Q1 202211,105$433.0K<0.1%+3,608+48.1%AddedHolders
Q4 20217,497$299.0K<0.1%+7,497NewHolders
Q3 20210$00.0%−928−100.0%Sold outHolders
Q2 2021928$38.0K<0.1%+23+2.5%AddedHolders
Q1 2021905$39.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.